Delivery of Drugs (Atorvastatin, Pentoxyphillin, Nitroglycerin, Insulin-Isophan Human Genetically Engineering)

RussiaTenders notice for Delivery of Drugs (Atorvastatin, Pentoxyphillin, Nitroglycerin, Insulin-Isophan Human Genetically Engineering). The reference ID of the tender is 118251577 and it is closing on 05 May 2025.

100% Secure Payments

Tender Details

  • Country: Russia
  • Summary: Delivery of Drugs (Atorvastatin, Pentoxyphillin, Nitroglycerin, Insulin-Isophan Human Genetically Engineering)
  • RUT Ref No: 118251577
  • Deadline: 05 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 138201.69
  • Notice Type: Tender
  • Document Ref. No.: 32514790138
  • Purchaser's Detail :
  • Purchaser : STATE AUTONOMOUS INSTITUTION OF HEALTH CITY CLINICAL HOSPITAL NO. 9 CHELYABINSK
    454046, Chelyabinsk, Electric Street 5, D. 5
    F.I.O:- Babinets A.V.
    Number of contact phone:- +7 (351) 2560161
    Email :hospital9@mail.ru

  • Description :
  • Lot name:-supply of drugs (atorvastatin, pentoxyphillin, nitroglycerin, insulin-isophan human genetically-engineer)
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us